EirGenix Asset Resilience Ratio

Latest as of December 2024: 4.60%

EirGenix asset resilience ratio. EirGenix (6589) has an Asset Resilience Ratio of 4.60% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of EirGenix for a breakdown of total debt and financial obligations.

Liquid Assets

NT$500.00 Million

≈ $15.75 Million USD Cash + Short-term Investments

Total Assets

NT$10.88 Billion

≈ $342.67 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of EirGenix (2017–2024)

Asset resilience ratio of EirGenix from 2017 to 2024. This chart shows how EirGenix's Asset Resilience Ratio has changed over time. See how much free cash does EirGenix generate to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down EirGenix's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EirGenix total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$500.00 Million	4.6%
Total Liquid Assets	NT$500.00 Million	4.60%

Asset Resilience Insights

Limited Liquidity: EirGenix maintains only 4.60% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

EirGenix Industry Peers by Asset Resilience Ratio

Compare EirGenix's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

EirGenix Asset Resilience Ratio by Year (2017–2024)

EirGenix asset resilience ratio by year from 2017 to 2024. The table below shows the annual Asset Resilience Ratio data for EirGenix.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.60%	NT$500.00 Million ≈ $15.75 Million	NT$10.88 Billion ≈ $342.67 Million	+0.12pp
2023-12-31	4.48%	NT$500.00 Million ≈ $15.75 Million	NT$11.16 Billion ≈ $351.68 Million	-3.96pp
2022-12-31	8.44%	NT$1.00 Billion ≈ $31.51 Million	NT$11.85 Billion ≈ $373.25 Million	-6.11pp
2021-12-31	14.55%	NT$1.66 Billion ≈ $52.45 Million	NT$11.44 Billion ≈ $360.45 Million	+11.57pp
2020-12-31	2.99%	NT$114.52 Million ≈ $3.61 Million	NT$3.84 Billion ≈ $120.83 Million	-6.67pp
2017-12-31	9.65%	NT$163.64 Million ≈ $5.16 Million	NT$1.70 Billion ≈ $53.41 Million	--

pp = percentage points

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#10680 Global

#387 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.00%

52-Week Range

NT$66.40 - NT$66.40

All Time High

NT$188.50